Crenigacestat
Crenigacestat (LY3039478) is a potent, orally bioavailable small molecule inhibitor of Notch signaling, demonstrating an IC50 of ~1 nM in various tumor cell lines. It effectively suppresses mutant Notch receptor activity and, in xenograft models, reduces Notch target gene expression and N1ICD cleavage within tumors. This inhibitor is a valuable research tool for studying Notch pathway roles in cancer and other diseases in both in vitro and in vivo settings.
Product Specifications
CAS Number
1421438-81-4
Product Name Alternative
Gamma secretase, Gammasecretase, LY3039478, LY-3039478, LY 3039478, liver, Notch-1, Notch, inhibit, Inhibitor, CCRCC, Crenigacestat, γ-secretase
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Purity
97.27% (May vary between batches)
Solubility
DMSO:150 mg/mL (322.97 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.31 mM)
Smiles
C[C@H] (NC (=O) CCC (F) (F) F) C (=O) N[C@H]1c2ccccc2-c2cccnc2N (CCO) C1=O
Molecular Formula
C22H23F3N4O4
Molecular Weight
464.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
BC048943 Lentiviral Activation Particles (m2)
FITC Armenian Hamster IgG Isotype Control (PIP) Antibody
FITC Armenian Hamster IgG Isotype Control (PIP) Antibody
Magic™ Membrane Protein Human IL7R (Interleukin 7 receptor) for Antibody Discovery